Spanish Red Biotech Pipeline

ADNTRO

ADNTRO Pharmacogenetics

Type: Biomarkers
Therapeutic area: Others
Indication: Clinical dosing guidelines for more than 60 drugs - haplotypes analysis
Phase: 5Ready to Market, 4Register, 3Clinical validation, 2Preclinical Validation, 1R+D
Studies location: Worldwide